Displaying drugs 14251 - 14275 of 14739 in total
Seladelpar
Seladelpar (MBX-8025) has been used in trials studying the treatment of Hyperlipidemia.
Investigational
Candoxatril
Candoxatril is the orally-active prodrug of candoxatrilat (UK-73967), a potent neutral endopeptidase (NEP) inhibitor.
Experimental
A-98881
Experimental
N-[Tosyl-D-Prolinyl]Amino-Ethanethiol
Experimental
BMS-564929
BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental
CCT-018159
Experimental
(S)-famoxadone
Experimental
SD-0006
Investigational
Alphamethadol
Experimental
Illicit
4-Flourobenzenesulfonamide
Experimental
AL5424
Experimental
3-Amino-4-Oxybenzyl-2-Butanone
Experimental
Phenylacetaldehyde
Experimental
AL7089A
Experimental
Displaying drugs 14251 - 14275 of 14739 in total